{"id":47552,"date":"2017-09-06T06:43:03","date_gmt":"2017-09-06T10:43:03","guid":{"rendered":"https:\/\/asweetlife.org\/?p=47552"},"modified":"2017-09-06T06:02:18","modified_gmt":"2017-09-06T10:02:18","slug":"how-gene-editing-might-reshape-diabetes-treatment","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=47552","title":{"rendered":"How Gene Editing Might Reshape Diabetes Treatment"},"content":{"rendered":"

The public was agog \u2013 and a little nervous \u2013 when the announcement came out this summer that researchers had \u201cedited\u201d the genes of human embryos, removing a mutation that causes a potentially fatal heart disease<\/a>.<\/p>\n

The embryos were created for the research and will not be implanted. But the study is intended to show that CRISPR\/Cas9 technology could be used to remove disease-causing genes effectively and efficiently, not just creating a healthy embryo but allowing the edited genes to be carried into future generations, potentially eliminating the disease from the gene pool.<\/p>\n

The number of inherited diseases\u2014or increased risk of disease\u2014that might be avoided this way is staggering. But the concerns are big ones<\/a>: At what point might this lead to designer babies? Will we reach the point of thinking that genes linked to basic individual traits such as short height or curly hair are problematic? Even if such a thing should never happen, there are worries about making changes to the human germline that will be inherited from that point on. The potential consequences are unknown.<\/p>\n

But there\u2019s a less controversial side of gene editing with CRISPR\/Cas9 that has life-changing potential for people with many diseases and conditions, including diabetes. Various research projects are under way to find treatments or possibly cures by modifying people\u2019s cells.<\/p>\n

CRISPR stands for \u201cclustered regularly interspaced short palindromic repeats,\u201d segments of the genetic code. Cas9 is an enzyme that has been likened to scissors that, with the guidance of CRISPR, can cut DNA with extraordinary precision, removing a segment and replacing it with a new one.<\/p>\n

The newest research on using CRISPR\/Cas9 to treat diabetes came out in August. Researchers created genetically edited skin grafts<\/a> that protected mice from diabetes and from gaining larger amounts of weight that are associated with Type 2 diabetes. The idea is that such grafts might be usable in humans one day as long-term replacements for insulin shots.<\/p>\n

The researchers \u201cinserted the gene for glucagon-like peptide 1 (GLP1),<\/em> a hormone that stimulates the pancreas to secrete insulin,\u201d the University of Chicago announced<\/a>. \u201cThis extra insulin removes excessive glucose from the bloodstream, preventing the complications of diabetes.\u00a0GLP1<\/em>\u00a0can also delay gastric emptying and reduce appetite.\u201d<\/p>\n

There\u2019s a history of promising mouse studies that fail to translate into human diabetes treatments, but the researchers don\u2019t see the same problems for this technology because skin grafts have long been used effectively for human burn victims.<\/p>\n

\u201cSkin progenitor cells have several unique advantages that are a perfect fit for gene therapy,\u201d the university announcement said. \u201cHuman skin is the largest and most accessible organ in the body. It is easy to monitor. Transplanted skin can be quickly removed if necessary. Skins cells rapidly proliferate in culture and can be easily transplanted. The procedure is safe, minimally invasive and inexpensive.\u201d<\/p>\n

Other researchers have been working on more expansive treatments for diabetes using CRISPR\/Cas9.<\/p>\n

Last year, Lund University Diabetes Center<\/a> in Sweden reported that researchers there, working with rats, had turned off an enzyme that regulates a gene associated with diabetes.<\/p>\n

\u201cThe results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells,\u201d the center announced.<\/p>\n

The researchers examined a group of enzymes called HATs, or histone acetyltransferases, involved in regulating the TXNIP gene. \u201cThe TXNIP gene, in cases of high blood sugar levels, leads to beta cell death and reduced insulin production,\u201d the diabetes center reported.<\/p>\n

They found the gene activity of those enzymes was twice as high in diabetic cells than healthy ones. They then used CRISPR\/Cas9 to remove and replace a genetic sequence that controls the enzymes.<\/p>\n

\u201cThis resulted in reduced TXNIP gene activity and thereby reduced cell death and increased insulin production,\u201d the diabetes center announced.<\/p>\n

At a more basic-research level, a researcher at the Walter and Eliza Hall Institute in Australia<\/a> won a grant in 2015 to determine whether CRISPR technology could be used to locate rogue immune cells that attack the pancreas, causing Type 1 diabetes.<\/p>\n

And a researcher at the Joslin Diabetes Center<\/a> in Boston has been using CRISPR-Cas9 to create mouse models of Type 1 diabetes for use in research.<\/p>\n

The technology is still in early experimental stages for the most part, and scientists have some concerns about whether its high precision is precise enough.<\/p>\n

They\u2019ve noted that the scissoring and replacement might make unanticipated changes to other parts of the genome, called \u201coff-target effects.\u201d<\/p>\n

\u201cWe think we can get off-target effects to less than 1 percent, but we need to do better,\u201d Dr. J. Keith Joung of Massachusetts General Hospital told Stat News<\/a> in 2016. The article raises questions about whether scientists are so excited about their new ability to cut out troubled patches of genetic material and replace it, that they\u2019re not paying enough attention to the problems even small imperfections in the technology might cause.<\/p>\n

At the same time, such concerns aren\u2019t going to slow the pace of technology that seems to offer so much hope for so many diseases and conditions.<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

…<\/p>\n","protected":false},"author":225,"featured_media":47557,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1445],"tags":[],"yoast_head":"\nHow Gene Editing Might Reshape Diabetes Treatment<\/title>\n<meta name=\"description\" content=\"The public was agog and a little nervous when the announcement came out this summer that researchers had \u201cedited\u201d the genes of human embryos...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=47552\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karin Klein\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=47552\",\"url\":\"https:\/\/asweetlife.org\/?p=47552\",\"name\":\"How Gene Editing Might Reshape Diabetes Treatment\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47552#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47552#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/09\/how-gene-editing-might-reshape-diabetes-treatment-2-scaled.jpg\",\"datePublished\":\"2017-09-06T10:43:03+00:00\",\"dateModified\":\"2017-09-06T10:02:18+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/491c25e479c7d735268e0b33b65868b6\"},\"description\":\"The public was agog and a little nervous when the announcement came out this summer that researchers had \u201cedited\u201d the genes of human embryos...\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47552#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=47552\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=47552#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/09\/how-gene-editing-might-reshape-diabetes-treatment-2-scaled.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/09\/how-gene-editing-might-reshape-diabetes-treatment-2-scaled.jpg\",\"width\":2560,\"height\":1556,\"caption\":\"How Gene Editing Might Reshape Diabetes Treatment\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=47552#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Gene Editing Might Reshape Diabetes Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/491c25e479c7d735268e0b33b65868b6\",\"name\":\"Karin Klein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f4c906a1dfa4e8aded2168a7743a86ec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f4c906a1dfa4e8aded2168a7743a86ec?s=96&d=mm&r=g\",\"caption\":\"Karin Klein\"},\"description\":\"Karin Klein is a freelance journalist based in Southern California who specializes in writing about health and medicine, education, environment and food. For 27 years, she covered those topics at the Los Angeles Times as an editor and editorial writer. Karin is a graduate of Wellesley College, where she majored in linguistics, and she studied journalism at UC Berkeley's Graduate School of Journalism. When she's not writing, she's usually found on hiking trails and is the author of an interpretive hiking book, \\\"50 Hikes in Orange County.\\\"\",\"url\":\"https:\/\/asweetlife.org\/?author=225\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How Gene Editing Might Reshape Diabetes Treatment","description":"The public was agog and a little nervous when the announcement came out this summer that researchers had \u201cedited\u201d the genes of human embryos...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=47552","twitter_misc":{"Written by":"Karin Klein","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=47552","url":"https:\/\/asweetlife.org\/?p=47552","name":"How Gene Editing Might Reshape Diabetes Treatment","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=47552#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=47552#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/09\/how-gene-editing-might-reshape-diabetes-treatment-2-scaled.jpg","datePublished":"2017-09-06T10:43:03+00:00","dateModified":"2017-09-06T10:02:18+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/491c25e479c7d735268e0b33b65868b6"},"description":"The public was agog and a little nervous when the announcement came out this summer that researchers had \u201cedited\u201d the genes of human embryos...","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=47552#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=47552"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=47552#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/09\/how-gene-editing-might-reshape-diabetes-treatment-2-scaled.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/09\/how-gene-editing-might-reshape-diabetes-treatment-2-scaled.jpg","width":2560,"height":1556,"caption":"How Gene Editing Might Reshape Diabetes Treatment"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=47552#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"How Gene Editing Might Reshape Diabetes Treatment"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/491c25e479c7d735268e0b33b65868b6","name":"Karin Klein","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f4c906a1dfa4e8aded2168a7743a86ec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f4c906a1dfa4e8aded2168a7743a86ec?s=96&d=mm&r=g","caption":"Karin Klein"},"description":"Karin Klein is a freelance journalist based in Southern California who specializes in writing about health and medicine, education, environment and food. For 27 years, she covered those topics at the Los Angeles Times as an editor and editorial writer. Karin is a graduate of Wellesley College, where she majored in linguistics, and she studied journalism at UC Berkeley's Graduate School of Journalism. When she's not writing, she's usually found on hiking trails and is the author of an interpretive hiking book, \"50 Hikes in Orange County.\"","url":"https:\/\/asweetlife.org\/?author=225"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47552"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/225"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47552"}],"version-history":[{"count":5,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47552\/revisions"}],"predecessor-version":[{"id":47558,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47552\/revisions\/47558"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/47557"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}